当前位置：
X-MOL 学术
›
J. Rheumatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A Retrospective Analysis of Outcome in MDA5-Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus.
The Journal of Rheumatology ( IF 3.9 ) Pub Date : 2022-08-15 , DOI: 10.3899/jrheum.220367 Li Fan 1 , Wenting Lyu 1 , Huarui Liu 1 , Hanyi Jiang 1 , Lulu Chen 1 , Yin Liu 1 , Yi Zhuang 1 , Mei Huang 1 , Min Cao 1 , Hourong Cai 1 , Yonglong Xiao 1 , Jinghong Dai 1
The Journal of Rheumatology ( IF 3.9 ) Pub Date : 2022-08-15 , DOI: 10.3899/jrheum.220367 Li Fan 1 , Wenting Lyu 1 , Huarui Liu 1 , Hanyi Jiang 1 , Lulu Chen 1 , Yin Liu 1 , Yi Zhuang 1 , Mei Huang 1 , Min Cao 1 , Hourong Cai 1 , Yonglong Xiao 1 , Jinghong Dai 1
Affiliation
The efficacy of tofacitinib in early diagnosis of MDA5-ILD has been described. But whether tofacitinib exposure is associated with a reduced one-year mortality remains undetermined.
中文翻译：
托法替尼或他克莫司治疗 MDA5 相关间质性肺病结果的回顾性分析。
托法替布在 MDA5-ILD 早期诊断中的功效已有报道。但托法替布暴露是否与一年死亡率降低相关仍不确定。
更新日期：2022-08-15
中文翻译：
托法替尼或他克莫司治疗 MDA5 相关间质性肺病结果的回顾性分析。
托法替布在 MDA5-ILD 早期诊断中的功效已有报道。但托法替布暴露是否与一年死亡率降低相关仍不确定。
京公网安备 11010802027423号